These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22221307)

  • 21. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erectile dysfunction.
    Katz A; Katz A
    CMAJ; 2010 Mar; 182(4):381-2. PubMed ID: 20142374
    [No Abstract]   [Full Text] [Related]  

  • 23. The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers.
    Shaeer O
    J Sex Med; 2013 Feb; 10(2):532-40. PubMed ID: 23088586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of ED under the "severe distress" criteria in the NHS: a real-life study.
    Mohee A; Bretsztajn L; Storey A; Eardley I
    J Sex Med; 2014 Apr; 11(4):1056-1062. PubMed ID: 24382018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study.
    Cairoli C; Reyes LA; Henneges C; Sorsaburu S
    Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How new drugs help treat erectile dysfunction.
    Weeks B; Ficorelli CT
    Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
    [No Abstract]   [Full Text] [Related]  

  • 28. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S
    Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil or vardenafil nonresponders' erectile response to tadalafil.
    Ozgur BC; Gonenc F; Yazicioglu AH
    Urol J; 2009; 6(4):267-71. PubMed ID: 20027555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and medical management of erectile dysfunction in Asia.
    Park K; Hwang EC; Kim SO
    Asian J Androl; 2011 Jul; 13(4):543-9. PubMed ID: 21460862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
    Hsu JC; Tang DH; Lu CY
    Int J Clin Pract; 2015 Apr; 69(4):436-43. PubMed ID: 25311239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T; Gleissner J; Merfort F; Hermanns M; Beneke M; Ulbrich E
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vardenafil (levitra): new aspects of clinical efficacy].
    Gamidov SI; Iremashvili VV; Pavlovichev AA; Tazhetdinov OKh
    Urologiia; 2010; (6):44-7. PubMed ID: 21427994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDEI-5 for erectile dysfunction: a potential role in seizure susceptibility.
    Matos G; Scorza FA; Cavalheiro EA; Tufik S; Andersen ML
    J Sex Med; 2012 Aug; 9(8):2111-21. PubMed ID: 22613050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class.
    Shindel AW
    J Sex Med; 2009 Sep; 6(9):2352-64; quiz 2365-6. PubMed ID: 19735356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.
    Martín-Morales A; Graziottin A; Jaoudé GB; Debruyne F; Buvat J; Beneke M; Neuser D
    J Sex Med; 2011 Oct; 8(10):2831-40. PubMed ID: 21679304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor.
    Shaw JW; Reardon G; Sandor DW; Rosen RC; Ferguson DM
    J Sex Med; 2010 Mar; 7(3):1147-59. PubMed ID: 20113397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
    Rosen RC; McKenna KE
    Annu Rev Sex Res; 2002; 13():36-88. PubMed ID: 12836729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.